Skip to content

Clinical trials

Attention Deficit Disorder with Hyperactivity trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Attention Deficit Disorder with Hyperactivity Country / region: Sweden Clear all

60 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20051
20071
20084
20091
20105
20114
20125
20132
20142
20153
20163
20181
20195
20203
20214
20221
20236
20242
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42
Recruiting8
Unknown status5
Active, not recruiting4
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Karolinska Institutet20
Shire9
Eli Lilly and Company4
Uppsala University3
Göteborg University2
Halmstad University2
Novartis Pharmaceuticals2
Region Skane2
Region Stockholm2
Region Västmanland2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Attention Deficit Disorder with Hyperactivity60
Anxiety Disorders7
Autism Spectrum Disorder6
Autistic Disorder4
Neurodevelopmental Disorders4
Intellectual Disability3
Parasomnias3
Stress Disorders, Post-Traumatic3
Bipolar Disorder2
Sleep Initiation and Maintenance Disorders2

Trials

Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.